NU. International Journal of Science 2016; 13(1) :

Similar documents
FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS

Formulation and Evaluation

SUPPLEMENTARY MATERIAL Antiradical and antioxidant activity of flavones from Scutellariae baicalensis radix

THIN LAYER CHROMATOGRAPHY

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

STUDY OF THE DETERIORATION OF ASPIRIN IN THE PRESENCE OF VARIOUS EXCIPIENTS

OPTIMIZATION OF MICROWAVE-ASSISTED EXTRACTION OF BIOACTIVE COMPOUNDS FROM LEAVES AND STEMS OF THAI WATER SPINACH (Ipomoea aquatic var.

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium

Short Communication. Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L. J. TIROP AND K. A. M.

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

SIMAROUBA CEDRON FOR HOMOEOPATHIC PREPARATIONS CEDRON FOR HOMOEOPATHIC PREPARATIONS

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

STANDARD OPERATING PROTOCOL (SOP)

Subcritical Water Extraction of Polyphenolic Compounds from Terminalia chebula Fruits

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

Qualitative and quantitative determination of phenolic antioxidant compounds in red wine and fruit juice with the Agilent 1290 Infinity 2D-LC Solution

USP Method Transfer of Ziprasidone HCl from HPLC to UPLC

F. Al-Rimawi* Faculty of Science and Technology, Al-Quds University, P.O. Box 20002, East Jerusalem. Abstract

A HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY FOR LERCANIDIPINE HYDROCHLORIDE

Study of Disintegrant Property of Moringa Oleifera Gum and its Comparison with other Superdisintegrants

Analysis of Isoflavones with the PerkinElmer Flexar FX-15 UHPLC System Equipped with a PDA Detector

Available online Research Article

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

Simultaneous estimation of Metformin HCl and Sitagliptin in drug substance and drug products by RP-HPLC method

Application Note. Treatment of poor memory, memory loss, Alzheimer s disease, peripheral vascular disease.

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Research Article GALLIC ACID AND FLAVONOID ACTIVITIES OF AMARANTHUS GANGETICUS

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION

Pelagia Research Library

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

Validation of Changes to the USP Assay Method for Ibuprofen Tablets

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

Formulation and evaluation of immediate release salbutamol sulphate

IJPRD, 2011; Vol 4(03): May-2012 ( ) International Standard Serial Number

Chapter 2 Biochemical changes and antioxidant activity of elephant- foot yam corm during development

Amudha S et al., Asian Journal of Pharmthiaceutical Technology & Innovation, 04 (21); 2016; Research Article

Tramadol Hydrochloride Extended-Release Tablets. Expert Committee Chemical Medicines Monographs 2 Reason for Revision Compliance

Optimization of extraction method and profiling of plant phenolic compounds through RP-HPLC

Volume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL

HPLC to UHPLC Transfer of USP Method for Amlodipine Besylate Using the Agilent 1290 Infinity II LC

CHAPTER 8 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) ANALYSIS OF PHYTOCHEMICAL CONSTITUENTS OF M. ROXBURGHIANUS AND P. FRATERNUS PLANT EXTRACTS

STARCH Application Data

PAPRIKA EXTRACT SYNONYMS DEFINITION DESCRIPTION FUNCTIONAL USES CHARACTERISTICS

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

[ APPLICATION NOTE ] The Separation of 8 -THC, 9 -THC, and Their Enantiomers by UPC 2 Using Trefoil Chiral Columns INTRODUCTION APPLICATION BENEFITS

Bioequivalence Studies of Two Formulations of Famciclovir Tablets by HPLC Method

Analysis of Counterfeit Antidiabetic Drugs by UHPLC with the Agilent 1220 Infinity Mobile LC

FLORITER. New Technology for Innovative Formulation Design.

Pelagia Research Library

Preparation and characterization of Aloe vera extract

Antioxidative activities and phenolic compounds of pumpkin (Cucurbita pepo) seeds and amaranth (Amaranthus caudatus) grain extracts

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

Pelagia Research Library

Isolation of five carotenoid compounds from tangerine tomatoes

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

contents of the monograph in effect today. Please refer to the current edition of the USP NF for official text.

Rapid Gradient and Elevated Temperature UHPLC of Flavonoids in Citrus Fruit

Development and Validation of Improved RP-HPLC method for Identification and Estimation of Ellagic and Gallic acid in Triphala churna

Analysis of Common Sweeteners and Additives in Beverages with the PerkinElmer Flexar FX-15 System Equipped with a PDA Detector

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

Formulation and evaluation of sublingual tablets of lisinopril

J Pharm Sci Bioscientific Res (4): ISSN NO

Simultaneous determination of triacetin, acetic ether, butyl acetate and amorolfine hydrochloride in amorolfine liniment by HPLC

DEVELOPMENT OF RP-HPLC METHOD FOR ESTIMATION OF DROTAVERINE HYDROCHLORIDE IN PHARMACEUTICAL FORMULATIONS

Quetiapine Tablets. Expert Committee Monographs Chemical Medicines 4 Reason for Revision Compliance

STABILITY INDICATING ASSAY. differentiate an intact drug from its potential decomposition products 425.

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

Optimization of valsartan tablet formulation by 2 3 factorial design

Keywords: antioxidant; extraction; paper flower; phenolic compound

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

Design and In-vitro Evaluation of Silymarin Bilayer Tablets

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS

Scholars Research Library

Application Note Soy for Isoflavones by HPLC. Botanical Name: Glycine max L. Common Names: Parts of Plant Used: Beans.

Pharmacologyonline 3: (2009) Newsletter Pawar and Surana

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS

Title Revision n date

Tentu Nageswara Rao et al. / Int. Res J Pharm. App Sci., 2012; 2(4): 35-40

Research Article. ISSN Available online at 746

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

Determination of total phenolic, flavonoid content and free radical scavenging activities of common herbs and spices.

A simple validated RP-HPLC method for quantification of sumatriptan succinate in bulk and pharmaceutical dosage form

SIMULTANEOUS ESTIMATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN TABLETS BY RP-HPLC METHOD

Impurity Profiling of Carbamazepine by HPLC/UV

Purification and identification of flavonoids in Portualca olearcea by macroporous adsorption resin and HPLC

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

SUMMARY, CONCLUSION & RECOMMENDATIONS

Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig

Scholars Research Library

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

Rapid and sensitive UHPLC screening for water soluble vitamins in sports beverages

Transcription:

NU. International Journal of Science 2016; 13(1) : 17 25 17 Comparative Evaluation on Rutin Content, Radical Scavenging Activity and Properties of Tablets Prepared from Noni Leaf and Fruit Extracts Supavadee Boontha 1, Abhinant Chumchuensanoi 1, Wiparat Charachit 1, Chanokophon Deepaen 1, Chawalee Jareontanakul 1, Saowinee Wongmano 1, Tasana Pitaksuteepong 2 1 School of Pharmaceutical Sciences, University of Phayao, Phayao 56000, Thailand 2 Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand *Corresponding author. E-mail: supa0865@hotmail.com ABSTRACT The purpose of this study was to evaluate the rutin content and radical scavenging activity of the leave and fruit extracts of Morinda citrifolia (Noni). The preparation and evaluation of tablets containing the Noni leaf and fruit extracts were also aimed. In this study, the leaves and fruits of Noni were prepared by maceration technique. Their rutin content and antioxidant activity were determined by using High Performance Liquid Chromatography (HPLC) and 1, 1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging assay, respectively. The tablets containing theses extracts were prepared and their physical properties, including thickness and hardness, weight variation and disintegration time (DT) were evaluated. Additionally, the physicochemical stability was evaluated for three months period at 45 o C and relative humidity of 75 %. The results showed that Noni leave extract had similar rutin content and antioxidant activity compared to the fruit extract. The physical properties of tablets prepared from these extracts were met the requirements of USP XXX. Following stability test, rutin content and antioxidant activity of the extract and all tablet formulations were decreased. Keywords: Morinda citrifolia L, rutin content, radical scavenging activity, physical properties INTRODUCTION Antioxidants play an important role in inhibiting and scavenging free radicals, thus providing protection to human against infections and degenerative diseases. Current research is now focused towards natural antioxidants originated from plants due to safe therapeutics. Morinda citrifolia L (Noni) (Family: Robiaceae), a medicinal plant commonly known in Thai as Yor, has

18 NU. International Journal of Science 2016; 13(1) : 17 25 been reported to have broad therapeutic effects, including anti-inflammatory (McKoy et al. 2002), hypoglycemic (Nayak et al. 2011) and antioxidant (Wang et al. 2009) activities, in both clinical practice and laboratory animal models. In many countries, leaves and fruits of Noni are used as a treatment in traditional medicine. The leaves are mostly frequently used for external treatments such as rheumatic or swelling joints, broken bones and boil and burn, whereas the fruits used for internal treatment such as antiemetic agents, hypertension and diabetes (Pawlus and Kinghorn, 2007, Yang et al. 2011). It has been reported that the extract from Noni leaf and fruit exhibited a promising activity in DPPH scavenging and total phenolic content (Yang et al. 2011). Studies have shown Noni leaf and fruit contains several phenolic compounds including ursolic acid, kaempferol, quercetin and rutin. Rutin has been reported to have antioxidant, anti- diabetic and anti- inflammatory activity (Thani et al. 2010). Moreover, rutin has been used as a marker of antioxidant activity of Noni (Yang et al. 2011) and the differences of rutin content of Noni leaves and fruits have been not identified. Annually, the market sales of Noni products claimed to reach up to US $1.3 billion (Potterat and Hamburger, 2007). However, Noni products such as liquid dietary supplement or Tahitian Noni Juice are generally available in liquid dosage forms (Wang et al. 2009, Wang and Su, 2001). The liquid dosage form is inconvenient for the user, inaccurate amount of drug administration and unpleasant taste. Tablets are more preferable, stable and convenient alternative (Kucinskaite et al. 2007). Therefore, this investigation was aimed to determine the rutin content and radical scavenging activity of the leave and fruit extracts. The preparation and evaluation of tablets from the Noni leaf and fruit extracts were also included. METHODOLOGY Preparation of Noni leaf and fruit extracts The leaves and fruits of Noni were collected from Phayao and Nakhon ratchasrima, Thailand, in August-October, 2013. The fresh leaves and fruits were washed and air dried. They were further dried at 50 o C using a hot-air oven (Memmert, Germany) for 48 hours. After grounding into powder, they were macerated using 95% ethanol. It was then filtered and concentrated using a rotary evaporator (Heidolph, Germany). Percentage yield of the crude extracts was calculated by the following equation: % Yield = (weight of dried crude extract (g)/weight of dried noni (leaf/fruit) powder (g)) x 100 (1)

NU. International Journal of Science 2016; 13(1) : 17 25 19 Determination of rutin content in extracts The obtained extracts were analyzed for rutin, a marker, using High- Performance Liquid Chromatography (HPLC) (CBM-20Alite, Shimadzu, Japan). Chromatography was performed on phenomenex luna C18 column (5 µm, 150x4.60 mm) with a mobile phase of 0.01M acetic acid: methanol: acetonitrile (60:20:20) and a flow rate of 1.0 ml/min. The volume injected is 20 µl with detection at 254 nm. The ruin content was calculated based on peak area of HPLC chromatogram. Determination of antioxidant activity of the extracts The antioxidant activity was determined using 1, 1-diphenyl-2- picrylhydrazyl (DPPH) radical scavenging assay (Sigma Aldrich Chemicals, MO, USA) (Ghasemzadeh et al. 2011). Briefly, one ml of solution of Noni extracts was mixed with 9 ml of 0.2 mm DPPH in test tube. After incubation at RT for 30 min, the optical density at 515 nm (OD 515) of the mixture was determined by using UV-visible spectrophotometer (Jasco, Japan). Ascorbic acid was used as positive control. Experimental was repeated three times. The ability to scavenge the DPPH radical was calculated by the following equation: % Radical scavenging = (1-(sample OD 515/blank OD 515)) x 100 (2) Where the sample OD 515 is the absorbance of the test sample and the blank OD 515 is the absorbance of the blank (without test sample) at 515 nm. Preparation and evaluation of Noni tablets The tablets of Noni leaf and fruit extracts were prepared by wet granulation method. Two types of disintegrants including corn starch (CS) and sodium starch glycolate (SSG) were used. The ingredients and formulation code of Noni tablets are given in Table 1. Tablets were compressed by a hydraulic press (PerkinElmer, IL, USA) using a 10 mm in diameter round flat-faced punch at compaction force 2 kn. The prepared Noni tablets were further assessed for thickness and hardness (Erweka, Germany). Weight variation and disintegration time (DT, Erweka, Germany) based on the requirements of the USP XXX (2007).

20 NU. International Journal of Science 2016; 13(1) : 17 25 Table 1. Ingredients and formulation code of Noni tablets prepared. Ingredients Functions Amount (mg/tablet) Rx-1 Rx-2 Rx-3 Rx-4 Rx-5 Rx-6 Leave extract Active ingredient 8.0 - - 8.0 - - Fruits extract Active ingredient - 16.0 - - 16.0 - PVP K30 a Binder 38.0 mg/tab Corn starch (CS) b Disintegrant 83.0 83.0 83.0 - - - Sodium starch glycolate (SSG) b Disintegrant - - - 83.0 83.0 83.0 Magnesium stearate Lubricant 4.5 mg/tab Talcum Lubricant 13.5 mg/tab Microcrystalline cellulose qs to Diluent 500.0 mg/tab Note: a Binder was prepared as 10% w/w PVP K30, b Disintegrant was divided into 2 parts and added intra- and extra-granularly, c Ingredients were shown in amount of mg/ tablet Stability test The physicochemical stability was evaluated for three months period at 45 o C and relative humidity of 75%. Physical properties, rutin content and antioxidant activity of Noni tablets prepared were evaluated at day 0 and 90. For statistical analysis, the instrumental values were expressed as mean ± SD and were evaluated by oneway ANOVA with post hoc LSD test. All of these data, p-value of less than 0.05 was considered statistically significant difference. Determination of rutin content in Noni tablets For determination the rutin content in Noni tablets, the tablets prepared were triturated and then extracted by using methanol. The extract was filtered and 20 µl of filtrate was analyzed using HPLC as described above. Determination of antioxidant activity of Noni tablets For determination antioxidant activity of Noni tablets, the tablets prepared were triturated and then extracted by using ethanol. The extract was filtered and 1 ml of filtrate was assayed by DPPH method as described above.

NU. International Journal of Science 2016; 13(1) : 17 25 21 RESULTS AND DISCUSSION Rutin content and antioxidant activity of the extracts The Noni leaf and fruit extract were viscous greenish-brown and viscous yellowish-brown gum, respectively. Percentage yield of Noni leaf and fruit extract obtained were approximately 30% and 18%, respectively (Table 2). Using HPLC technique, the rutin peaks were well-resolved under isocratic elution with retention times of 3.3 min and the rutin content in Noni leaf and fruit extracts were 0.54 and 0.42 % (w/w), respectively. The Noni leaf extract (IC 50 = 1.35±0.02 mg/ml) was found to have similar antioxidant activity with the fruit extract (IC 50 = 1.52 ±0.04 mg/ml). This is in disagreement with Yang et al. (2011) work in which the antioxidant activity of Noni leaf extract was greater than the fruit extract. Table 2. The rutin content and antioxidant activity of leaf and fruit extract. Sample Yield (%) Rutin content (% w/w) DPPH radical scavenging activity (IC 50) Leave extract 29.61 0.54 ± 0.17 1.35 ± 0.02 mg/ml Fruit extract 17.93 0.42 ± 0.09 1.52 ± 0.04 mg/ml Ascorbic acid - 9.82 ± 0.09 µg/ml Physicochemical properties of Noni tablets Based on the color of extracts, the tablets prepared from the leaves extract was light green in color, while the tablets prepared from the fruit extract was light brown in color (Figure 1). The tablets prepared without the extract was white in color. All prepared tablets had a smooth shiny surface with a round shape 10.00 ± 0.43 mm in diameter and an approximately 3.08 ± 0.08 mm thick.

22 NU. International Journal of Science 2016; 13(1) : 17 25 Rx-1 Rx-2 Rx-3 Rx-4 Rx-5 Rx-6 Fig. 1. The physical appearance of tablets prepared from various formulation. The physical properties of all of tablet formulations are given in Table 3. It was observed that the average thickness of the tablets also ranged from 2.98-3.23 nm. The hardness was in the range of 8.76-14.22 kg in all formulations, which falls above the limit of not less than 6 kg indicating good mechanical strength for packing process and transportation of the finished product requirement. The weight of all formulations was approximately 500 mg with compression at the specified weight. The maximum of weight variation of the tablet was ± 4.00%, which falls within the acceptable weight variation range of ± 5.00%, thus all of tablet formulations passed the weight variation test. According to the requirement of USP XXX, tablets should disintegrate within 15 min. It was observed that all formulations disintegrated within less than 6 min and the tablets prepared by using SSG presented slightly shorter disintegration time.

NU. International Journal of Science 2016; 13(1) : 17 25 23 Table 3. Physical properties of tablets containing Noni leaf and fruit extracts before stability test. Formulation Hardness (kg) Thickness (mm) Weight variation (mg) Physical properties Weight variation (%) Disintegration time (min) Rx-1 8.76±0.32 3.15±0.03 501.80±2.30 4.00 4.54±0.31 Rx-2 10.08±0.41 3.03±0.04 502.30±2.30 3.69 4.07±0.25 Rx-3 14.22±0.57 3.23±0.06 496.90±7.10 3.46 5.15±0.07 Rx-4 11.02±0.81 3.03±0.03 508.80±6.10 1.90 3.33±0.15 Rx-5 12.66±0.44 2.98±0.02 501.00±3.20 1.60 3.24±0.17 Rx-6 13.74±0.76 3.08±0.05 501.70±2.20 3.40 3.51±0.26 * Note: The requirement of USP standard: Disintegration time (DT) < 15 min Table 4. Physical properties of tablets containing Noni leaf and fruit extracts following stability test. Formulation Hardness (kg) Thickness (mm) Weight variation (mg) Physical properties Weight variation (%) Disintegration time (min) Rx-1 6.47±0.36 3.07±0.05 502.40±8.51 5.40 0.26±0.03 Rx-2 7.34±0.56 3.11±0.05 506.90±0.43 2.73 2.31±0.11 Rx-3 12.13±0.61 3.01±0.03 501.00±0.60 1.54 0.19±0.04 Rx-4 9.45±1.81 3.21±0.03 511.00±0.40 1.71 4.01±0.04 Rx-5 11.42±0.04 3.21±0.03 503.80±0.30 1.71 3.62±0.04 Rx-6 9.18±1.78 3.38±0.05 508.80±0.47 3.16 3.96±0.03 After stability test, the physical properties of all of tablet formulations are presented in Table 4. Compared to the data of day-0 tablets, the hardness of all tablet formulations was decreased whereas the thickness and weight variation of the tablets were increased. However, the variations were not alarming and remained within the acceptable range except Rx-1 with the maximum of weight variation of the tablet was ± 5.40% (Table 4). The hardness of tablets prepared was reduced what resulted in faster disintegration time except tablets prepared using SSG. Overall, Rx-5 showed better physical properties compared with the other formulations. The rutin content in the leaf, fruit extracts and all Noni tablet formulations were decreased following stability as shown in Figure 2a. However, the decrease in rutin content of the extracts and all tablet formulations were not significant. The DPPH scavenging activity of Noni leaf and fruit

24 NU. International Journal of Science 2016; 13(1) : 17 25 extract in crude extract and in tablet formulations were decreased significantly (p < 0.05) (Figure 2b). Rutin content (%) 140 120 100 80 60 40 20 0 1 2 3 4 5 6 Leaf Fruit Rx-1 Rx-2 Rx-4 Rx-5 Day 0 Day 90 DPPH radical scavenging activity (%) 100 80 60 40 20 0 1 2 3 4 5 6 Leaf Fruit Rx-1 Rx-2 Rx-4 Rx-5 Day 0 Day 90 a b Fig. 2. The rutin content (%) (a) and the DPPH radical scavenging activity (%) (b) of Noni leaf, fruit extract and all Noni tablet formulations (when analyzed at a concentration of the extract at 2 mg/ml) following stability test. CONCLUSIONS The present study demonstrated that Noni leave extract had similar rutin content and antioxidant activity compared to the fruit extract. The tablets containing Noni leaf and fruit extract were successfully prepared with the satisfied physical properties base on the requirement of USP XXX. Rutin content and antioxidant activity of the extract and all tablet formulations were decreased after stability test. ACKNOWLEDGMENTS This work was financially supported by a research of senior project grant from Faculty of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand.

NU. International Journal of Science 2016; 13(1) : 17 25 25 REFERENCES McKoy, M.L.G., Thomas, E.A. and Simon O.R. (2002). Preliminary Investigation of the Anti-inflammatory Properties of an Aqueous Extract from Morinda citrifolia (Noni). Proc. West. Pharmacol. Soc, 45, 76 78. Nayak, B.S., Marshall, J.R., Isitor, G.A. and Adogwa, A. (2011). Hypoglycemic and Hepatoprotective Activity of Fermented Fruit Juice of Morinda citrifolia (Noni) in Diabetic Rats. Evid. Based Complement. Alternat. Med, 1-5. Wang, M.Y., Peng, L., Hoper V.W., Deng, S., Anderson, G. and West, B.J. (2009). Noni Juice Improves Serum Lipid Profiles and Other Risk Markers in Cigarette Smokers. Scientific World J, 1-8. Pawlus A.D. and Kinghorn D. A. (2007). Review of the ethnobotany, chemistry, biological activity and safety of the botanical dietary supplement Morinda citrifolia (noni). J. Pharm. Pharmacol, 59(12), 1587-1609. Yang, J, Gadi, R. and Thomson, T. (2011). Antioxidant capacity, total phenols, and ascorbic acid content of noni (Morinda citrifolia) fruits and leaves at various storage of maturity. Micronesica, 41(2), 167-176. Thani, W., Vallisuta, O., Siripong, P. and Ruangwises, N. (2010). Anti-proliferative and antioxidative activites of Thai noni/yor (Morinda citrifolia Linn) leaf extract. Southeast Asian J. Trop. Med. Public Health, 41(2), 482-489. Potterat, O. and Hamburger, M. (2007). Morinda citrifolia (noni) fruit phytochemistry, pharmacology, safety. Planta Med, 73(3), 191 199 Wang, M.Y. and Su, C. (2001). Cancer Preventive Effect of Morinda citrifolia (Noni). Ann. N. Y. Acad. Sci, 952, 161-168. Kucinskaite, A., Sawicki, W., Briedis, V. and Szitowska, M. (2007). Fast Disintegrating Tablets Containing Rhodiola rosea L. Extract. Acta Pol. Pharm, 64(1), 63-67. Ghasemzadeh, A., Jaafar, H. Z. E. and Rahmat, A. (2011). Effects of solvent type on phenolics and flavonoids content and antioxidant activities in two varieties of young ginger (Zingiber officinale Roscoe) extracts. J. Med. Plants Res, 5(7), 1147-1154. United States Pharmacopoeia XXX. The USP Convention. 2007.